首页> 外文OA文献 >The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

【2h】

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

机译：BIG 2.04 MRC / EORTC SUPREMO试验：乳腺切除术后放疗对中危乳腺癌的大型3期随机国际临床试验的病理质量保证

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. S. Thomas; null null; A. M. Hanby; N. Russell; G. van Tienhoven; K. Riddle; N. Anderson; D. A. Cameron; J. M. S. Bartlett; T. Piper; C. Cunningham; P. Canney; I. H. Kunkler;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial (vol 19, pg 1516, 2018) [J] . Velikova G., Williams L. J., Willis S. The lancet oncology . 2018,第12期

机译：后期切除术后放疗后的患者的寿命质量（Supremo）：随机对照试验的2年后续结果（Vol 19，PG 1516,2018）
2. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised, controlled trial [J] . Velikova Galina, Williams Linda Jane, Willis Sarah, The lancet oncology . 2018,第11期

机译：中间风险乳腺癌患者的后切除放射治疗后的寿命质量（Supremo）：2年随机，对照试验的2年后续结果
3. The SUPREMO Trial - Pathology quality assurance of a large phase 3 randomised international clinical trial [J] . Thomas J., Hanby A., Van Tienhoven G., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Suppla2期

机译：SUPREMO试验-大型3期随机国际临床试验的病理质量保证
4. Translating Multiscale Cancer Models into Clinical Trials: Simulating Breast Cancer Tumor Dynamics within the Framework of the "Trial of Principle" Clinical Trial and the ACGT Project [C] . Eleni A. Kolokotroni, Georgios S. Stamatakos, Dimitra D. Dionysiou, IEEE International Conference on BioInformatics and BioEngineering . 2008

机译：将MultiSscale癌症模型转化为临床试验：在“原理试验”临床试验和ACGT项目的框架内模拟乳腺癌肿瘤动态
5. Sexuality and gynaecological cancer: A randomised control trial to evaluate the effectiveness of a group psychoeducational intervention in improving the sexual health of women with gynaecological cancer treated with radiotherapy [D] . Jeffries, Sherryl Anne 2003

机译：性与妇科癌症：一项随机对照试验，旨在评估团体心理教育干预措施对经放射治疗的妇科癌症妇女改善性健康的有效性
6. The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer [O] . J. S. Thomas, A. M. Hanby, N. Russell, -1

机译：BIG 2.04 MRC / EORTC SUPREMO试验：乳腺切除术后放疗对中危乳腺癌的大型3期随机国际临床试验的病理质量保证
7. The BIG 2.04 MRC/EORTC SUPREMO Trial - Pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer:pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer [O] . Thomas, J S, Hanby, A M, Russell, N, 2017

机译：BIG 2.04 mRC / EORTC sUpREmO试验 - 中度风险乳腺癌切除术后放疗的大型3期随机国际临床试验的病理学质量保证：中度风险乳房切除术后放疗的大型3期随机国际临床试验的病理学质量保证乳腺癌

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅